Schedule 13D ownership disclosure
ReShape Lifesciences Inc.
Security class unavailable · CUSIP: 76090R101
Event date: 2023-02-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 27.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000897069-23-000173
- Form type
- SC 13D
- Filer
- Matthew Joseph Nachtrab Revocable Trust 2014
- CIK
- CIK 1965608
- Filed
- Mar 17, 2023
- Reporting period
- Feb 06, 2023
- Description
- Schedule 13D beneficial ownership